Related Experiment Videos
Bupropion hydrochloride
Drug Intelligence & Clinical Pharmacy
|December 1, 1984
Summary
Bupropion is an effective antidepressant, showing superiority to placebo and comparable efficacy to other antidepressants with fewer side effects. While generally safe for adults and geriatrics, seizure induction is a notable adverse reaction.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Psychiatry
Background:
- Bupropion is a phenylaminoketone antidepressant.
- It lacks sedative, anticholinergic, and cardiotoxic effects.
- Its precise mechanism of action, potentially involving dopamine, is under investigation.
Purpose of the Study:
- To evaluate the efficacy and tolerability of bupropion as an antidepressant.
- To compare bupropion's safety and effectiveness against placebo and established antidepressants like amitriptyline and imipramine.
Main Methods:
- Controlled clinical trials involving over 1000 patients.
- Dosage range studied: 300-750 mg/day.
- Comparison groups included placebo, amitriptyline, and imipramine.
Main Results:
- Bupropion demonstrated superior efficacy compared to placebo.
- It was as well-tolerated as placebo and showed fewer side effects than amitriptyline or imipramine.
- The primary adverse event was seizure induction, comparable in frequency to imipramine.
Conclusions:
- Bupropion is a safe and effective antidepressant for adult and geriatric populations.
- It offers a favorable side effect profile compared to existing treatments.
- Further clinical use is needed to fully assess its long-term safety and efficacy.